Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Vermont for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Vermont only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Vermont (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Bla Partners, LLC (NPI 1548703556)

Key Findings

Field	Value
Entity Type	Organization
Organization	Bla Partners, LLC
Address	530 Community Dr
City	South Burlington
State	VT
ZIP	05403
Taxonomy	Clinical Medical Laboratory
NPI Enumerated	November 22, 2016

Payer Source	Total Paid
Medicaid	$15.2M
Medicare	$0

BLA PARTNERS, LLC is effectively a single-payer Medicaid billing entity: there is no Medicare billing on file and the provider reports $15.2M in total Medicaid revenue, indicating Medicaid accounts for the entirety of its documented public-payer activity. This profile signals the organization’s operations and revenue are concentrated in Medicaid populations rather than Medicare beneficiaries.

Revenue concentration is extreme among a small set of laboratory drug-testing codes: the top three Medicaid codes (G0480, 80307, G0481) together account for 100.0% of the provider’s Medicaid revenue, with G0480 alone representing $8.5M (56.2% of total) and 80307 contributing $5.8M (38.4% of total). This indicates nearly all Medicaid receipts derive from high-volume presumptive and definitive drug testing services.

The code mix and descriptions show BLA PARTNERS operates as a high-volume clinical testing lab focused on toxicology and drug monitoring. Primary revenue-driving codes are G0480 and G0481 (definitive drug identification via GC/MS or LC/MS methods) and 80307 (instrumented presumptive drug screens), which together imply a workflow that performs both large-scale screening and confirmatory definitive testing for multiple drug classes.

Competitive standing in Vermont’s Medicaid market is dominant for its top codes: the provider ranks #1 of 6 in-state for G0480 and #1 of 16 for 80307, both listed at the 100th percentile and described as notably above typical state volume or an extreme outlier. For G0481 it also ranks #1 (100th percentile) among 2 providers. These rank/percentile signals identify BLA PARTNERS as the leading in-state provider for both presumptive and definitive drug testing services.

The provider’s billing intensity shows very high claim volumes for specific laboratory services: 103.8K claims for G0480 and 102K claims for 80307 are reported, reflecting a transactional, high-throughput testing model likely serving many specimen sources per day. The combination of very large claim counts and modest average paid/claim values ($82 for G0480 and $57 for 80307) aligns with scale-driven laboratory operations rather than high-margin individualized procedures.

Tenure in the NPI registry is substantial: the NPI was enumerated on 2016-11-22 (~10 years ago), indicating the organization has been active long enough to establish an entrenched testing flow and statewide market position in its service lines. This duration supports the observed dominant rank positions rather than transient spikes.

Smaller, niche test codes are present but immaterial to overall Medicaid revenue: several single-digit-thousand-dollar codes (for example, 80348, 80349, 80360 and others) appear with very low revenue and rank #1 of 1 in-state for some, but they collectively contribute negligible dollars relative to the $15.2M total. These items likely represent occasional specialty assays or ancillary testing offered alongside the core drug-screening services.

Given the absence of Medicare billing and the concentration of Medicaid revenue in a narrow set of toxicology codes, payer mix risk is concentrated: any changes to Medicaid contracting, reimbursement, or utilization policies around presumptive and definitive drug testing could materially affect the provider’s revenue. Analysts should treat BLA PARTNERS as a Medicaid-centric, high-volume toxicology lab with leadership position in-state and limited diversification across other public payers.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

11 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but…	103,800	$80	$8.5M
80307	The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date.	102,040	$60	$5.8M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but…	5,770	$140	$825K
80348	The lab analyst measures the amount of or detects the presence of buprenorphine in a patient specimen. Buprenorphine is a drug used to treat opioid addiction, to control acute pain in individuals who…	390	$1	$1.6K
80349	The lab analyst measures the amount of or detects the presence of natural cannabinoids in a patient specimen.	150	$1	$610
80360	The lab analyst measures the amount of or detects the presence of methylphenidate, which is a central nervous system stimulant that treats attention deficit disorders, in the patient specimen.	40	$10	$270
80325	The lab analyst measures the amount of or detects the presence of three or four amphetamines, a central nervous system stimulant in the patient specimen.	40	$10	$250
80321	The lab analyst detects and measures the alcohol biomarker in a patient specimen. Alcohol biomarkers are physiological indicators of the alcohol exposure or ingestion. In this test, the analyst tests…	20	$10	$150
80324	The lab analyst measures the amount of or detects the presence of one or two amphetamines, a central nervous system stimulant in a patient specimen.	20	$1	$80
80359	The lab analyst measures the amount of or detects the presence of methylenedioxyamphetamines in the patient specimen.	20	$1	$80

Showing 1–10 of 11

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other Vermont providers billing the same CPT/HCPCS codes.

Claims Volume vs. Vermont Distribution

Bla Partners, LLC — 3 of 10 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Vermont

Full comparison — all codes billed, vs. Vermont median

11 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but…	1	10	660	$80	$1.5M
80307	The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date.	1	20	2,660	$50	$742.4K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but…	1	10	3,020	$140	$416.7K
81025	The lab analyst performs the pregnancy test on a urine specimen using a methodology or kit that the analyst can read visually for a direct readout.	18	20	170	$10	$5.2K
80348	The lab analyst measures the amount of or detects the presence of buprenorphine in a patient specimen. Buprenorphine is a drug used to treat opioid addiction, to control acute pain in individuals who…	1	10	390	$1	$1.7K
80349	The lab analyst measures the amount of or detects the presence of natural cannabinoids in a patient specimen.	1	10	150	$1	$680
80360	The lab analyst measures the amount of or detects the presence of methylphenidate, which is a central nervous system stimulant that treats attention deficit disorders, in the patient specimen.	1	10	40	$10	$270
80325	The lab analyst measures the amount of or detects the presence of three or four amphetamines, a central nervous system stimulant in the patient specimen.	1	10	40	$10	$250
80321	The lab analyst detects and measures the alcohol biomarker in a patient specimen. Alcohol biomarkers are physiological indicators of the alcohol exposure or ingestion. In this test, the analyst tests…	1	10	20	$10	$160
80324	The lab analyst measures the amount of or detects the presence of one or two amphetamines, a central nervous system stimulant in a patient specimen.	1	10	20	$1	$90

Showing 1–10 of 11

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nfi Vermont, Inc	VT	Clinic/Center	$0	$33.6M
Timberlane Dental Group	VT	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$7.5M
Tms Vt, LLC	VT	Durable Medical Equipment & Medical Supplies	$0	$2.9M
Michelle Young	VT	Ophthalmology Physician	$2.1M	$0
Howard Center Inc	VT	Psychiatry Physician	$0	$2M
Vermont Eye Surgery & Laser Center	VT	Ambulatory Surgical Clinic/Center	$1.8M	$2.7K
David Weissgold	VT	Ophthalmology Physician	$1.7M	$0
Surgi-care Inc	VT	Prosthetic/Orthotic Supplier	$0	$1.7M
City Of So Burlington	VT	Ambulance	$400.9K	$1M
Green Mountain Pediatric Dentistry, PLLC	VT	Pediatric Dentistry	$0	$1.3M

Bla Partners, LLC — Billing Profile & Reimbursement Data

Sign up for Bla Partners, LLC — Billing Profile & Reimbursement Data policy alerts

Bla Partners, LLC — Billing Profile & Reimbursement Data

Sign up for Bla Partners, LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References